Congratulations to 2025 Nobel Prize winner Fred Ramsdell, PhD, Sonoma Biotherapeutics co-founder, former Chief Scientific Officer, and current Chair of the Scientific Advisory Board.
Read more here: bit.ly/46DOMtH
Sonoma Biotherapeutics
285 posts
Sonoma Biotherapeutics
@sonomabio
Leading the next frontier of cell therapy
- We're collaborating with @Regeneron to discover, develop and commercialize potentially transformative #Treg therapies for people with #ulcerativecolitis, #crohns and other #autoimmune and #inflammatorydiseases. Learn more: bit.ly/40laZao. #IBD
00:00 - Thanks @NatureBiotech for sharing our story and mission to use the power of #Tregs to offer safe and durable control for #autoimmune and #inflammatory conditions. And thanks to @mklevings for naming us “the Treg dream team” – we are humbled and honored.
- Our CEO @kickassscience1 reflects on the significance of our $265M Series B financing and what it means for the future of the company as we look to address an unmet need in autoimmunity through the power of #celltherapy. Read more:
- We were honored to host Dr. Uché Blackstock, physician and founder of Advancing Health Equity, who spoke to the @SonomaBio team about inequities across the healthcare industry and #clinicaltrials. Thank you, @uche_blackstock, for leading this crucial conversation! #OneSonoma
- Today we’re honored to announce the completion of a $265M Series B financing funded by new and existing investors who believe in our team’s ability to tap into the potential of #celltherapy beyond cancer. sonomabio.com/news/sonoma-bi…
00:00 - Jeff Bluestone just raised $265M to develop curative cell therapies. We asked him how -
- We've expanded our novel #Treg cell therapy program, SBT-77-7101, to include #HidradenitisSuppurativa, and will be presenting preclinical data at @hsforg's #SHSA2023 tomorrow. Learn more about the data & our work in HS: sonomabio.com/2023/10/sonoma…
00:00 - Our co-founder and scientific advisor, Alexander Rudensky, put it perfectly when describing the potential therapeutic applications for our best-in-class #Tregs: “the future is rich.” Read more in @NatureBiotech: nature.com/articles/d4158…
- Congratulations to our CEO, @kickassscience1, on his election to the @theNASciences! We’re grateful for his expertise & leadership as we develop #Treg #celltherapies for #autoimmune and #inflammatory diseases. Read the release: bit.ly/BluestoneNAS. #NAS160 #NASmembers
00:00 - Our collaboration with @Regeneron is a joint effort to address an unmet need in those living with #ulcerativecolitis and #CrohnsDisease. Learn more about the collaboration to deliver #Treg therapies for #autoimmune and #inflammatory diseases: bit.ly/sonomabioregen… #IBD
00:00 - Our CEO, @kickassscience1 was interviewed for a recent @Nature article to share his insights on immune tolerance & the process of eliminating malfunctioning #immune cells to treat #autoimmune diseases. Read more: nature.com/articles/d4158…
- We're proud to share that our CEO @kickassscience1 has received @ImmunologyAAI's 2022 AAI-Steinman Award for Human Immunology Research. Read more about this year's career awards, and don't miss his lecture at #AAI2022 in May: bit.ly/3nkpNUY. Congrats, Jeff! #Immunology
- Our CEO, @kickassscience1, has been named to this year’s #PharmaVoice100 list honoring top leaders in #lifesciences. Learn more about Jeff's career and his work to develop #Treg cell therapies for #autoimmune and inflammatory diseases: bit.ly/3rsTmsK. @PharmaVoice
